Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,792.75
(
0.58%
)
News Focus
News Focus
Post# of 257660
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 48
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: ghmm post# 170903

Monday, 12/09/2013 12:44:02 PM

Monday, December 09, 2013 12:44:02 PM

Post# of 257660
Clinical Impact of Ponatinib Dose Modification in Patients with Philadelphia Chromosome–Positive Leukemias

A 15 mg reduction in average daily dose intensity is predicted to lead to ~40%
reduction in the risk of arterial thrombotic events


http://congressposters.ariad.com/downloads/packages/37/ASH2013_PACE_DoseMod_poster_FINAL.pdf

Thanks to @chasingthealpha
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today